Login / Signup

Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study.

Xin YanYuanyuan HuangJinlian XieQian WuShuang YangXiaoyan YangHonghui ChenJie HuangGuo-Ping Yang
Published in: Antimicrobial agents and chemotherapy (2024)
This study is registered with the International Clinical Trials Registry Platform as ChiCTR2300073525.
Keyphrases
  • double blind
  • clinical trial
  • placebo controlled
  • open label
  • phase iii
  • phase ii
  • study protocol
  • high throughput